ARNISOR Trademark

Trademark Overview

On Friday, December 17, 2010, a trademark application was filed for ARNISOR with the United States Patent and Trademark Office. The USPTO has given the ARNISOR trademark a serial number of 85200744. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 21, 2014. This trademark is owned by Glaxo Group Limited. The ARNISOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
arnisor

General Information

Serial Number85200744
Word MarkARNISOR
Filing DateFriday, December 17, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 21, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 23, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, July 21, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 21, 2014ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 19, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 18, 2013EXTENSION 5 GRANTED
Monday, December 9, 2013EXTENSION 5 FILED
Monday, December 9, 2013TEAS EXTENSION RECEIVED
Saturday, June 15, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 14, 2013EXTENSION 4 GRANTED
Friday, May 31, 2013EXTENSION 4 FILED
Friday, May 31, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 4, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, December 1, 2012EXTENSION 3 GRANTED
Thursday, November 29, 2012EXTENSION 3 FILED
Thursday, November 29, 2012TEAS EXTENSION RECEIVED
Wednesday, July 4, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 3, 2012EXTENSION 2 GRANTED
Monday, June 11, 2012EXTENSION 2 FILED
Friday, June 29, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 11, 2012TEAS EXTENSION RECEIVED
Friday, November 25, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 23, 2011EXTENSION 1 GRANTED
Wednesday, November 23, 2011EXTENSION 1 FILED
Wednesday, November 23, 2011TEAS EXTENSION RECEIVED
Tuesday, June 14, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 19, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 19, 2011PUBLISHED FOR OPPOSITION
Thursday, March 10, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 10, 2011ASSIGNED TO EXAMINER
Thursday, December 23, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, December 21, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

arnisor pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological